Search for: "U.S. v. Edwards" Results 1 - 20 of 2,323
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 May 2024, 6:30 am
Posted by the Harvard Law School Forum on Corporate Governance, on Friday, May 24, 2024 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of May 17-23, 2024 Statement by Chair Gensler on Amendments to Regulation S-P Posted by Gary Gensler, U.S. [read post]
24 May 2024, 6:30 am
Posted by the Harvard Law School Forum on Corporate Governance, on Friday, May 24, 2024 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of May 17-23, 2024 Statement by Chair Gensler on Amendments to Regulation S-P Posted by Gary Gensler, U.S. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
3 Apr 2024, 9:01 pm by renholding
Whether you’re here in person or participating virtually from around the country, or even overseas, I thank you for joining us. [read post]
28 Mar 2024, 8:07 pm by Patent Docs
The case arose with Edwards's challenge of claims 1-3, 5, 6, and 8-11 of Cardiovalve's U.S. [read post]